> Details

Bottermann, Katharina; Kalfhues, Lisa; Nederlof, Rianne; Hemmers, Anne; Leitner, Lucia M.; Oenarto, Vici; Nemmer, Jana; Pfeffer, Mirjam; Raje, Vidisha; Deenen, Rene; Petzsch, Patrick; Zabri, Heba; Köhrer, Karl; Reichert, Andreas S.; Grandoch, Maria; Fischer, Jens W.; Herebian, Diran; Stegbauer, Johannes; Harris, Thurl E.; Gödecke, Axel

Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Cardiomyocyte p38 MAPKα suppresses a heart–adipose tissue–neutrophil crosstalk in heart failure development
  • Contributor: Bottermann, Katharina; Kalfhues, Lisa; Nederlof, Rianne; Hemmers, Anne; Leitner, Lucia M.; Oenarto, Vici; Nemmer, Jana; Pfeffer, Mirjam; Raje, Vidisha; Deenen, Rene; Petzsch, Patrick; Zabri, Heba; Köhrer, Karl; Reichert, Andreas S.; Grandoch, Maria; Fischer, Jens W.; Herebian, Diran; Stegbauer, Johannes; Harris, Thurl E.; Gödecke, Axel
  • imprint: Springer Science and Business Media LLC, 2022
  • Published in: Basic Research in Cardiology
  • Language: English
  • DOI: 10.1007/s00395-022-00955-2
  • ISSN: 0300-8428; 1435-1803
  • Keywords: Physiology (medical) ; Cardiology and Cardiovascular Medicine ; Physiology
  • Origination:
  • Footnote:
  • Description: <jats:title>Abstract</jats:title><jats:p>Although p38 MAP Kinase α (p38 MAPKα) is generally accepted to play a central role in the cardiac stress response, to date its function in maladaptive cardiac hypertrophy is still not unambiguously defined. To induce a pathological type of cardiac hypertrophy we infused angiotensin II (AngII) for 2 days via osmotic mini pumps in control and tamoxifen-inducible, cardiomyocyte (CM)-specific p38 MAPKα KO mice (iCMp38αKO) and assessed cardiac function by echocardiography, complemented by transcriptomic, histological, and immune cell analysis. AngII treatment after inactivation of p38 MAPKα in CM results in left ventricular (LV) dilatation within 48 h (EDV: BL: 83.8 ± 22.5 µl, 48 h AngII: 109.7 ± 14.6 µl) and an ectopic lipid deposition in cardiomyocytes, reflecting a metabolic dysfunction in pressure overload (PO). This was accompanied by a concerted downregulation of transcripts for oxidative phosphorylation, TCA cycle, and fatty acid metabolism. Cardiac inflammation involving neutrophils, macrophages, B- and T-cells was significantly enhanced. Inhibition of adipose tissue lipolysis by the small molecule inhibitor of <jats:italic>adipocytetriglyceride lipase</jats:italic> (ATGL) Atglistatin reduced cardiac lipid accumulation by 70% and neutrophil infiltration by 30% and went along with an improved cardiac function. Direct targeting of neutrophils by means of anti Ly6G-antibody administration in vivo led to a reduced LV dilation in iCMp38αKO mice and an improved systolic function (EF: 39.27 ± 14%). Thus, adipose tissue lipolysis and CM lipid accumulation augmented cardiac inflammation in iCMp38αKO mice. Neutrophils, in particular, triggered the rapid left ventricular dilatation. We provide the first evidence that p38 MAPKα acts as an essential switch in cardiac adaptation to PO by mitigating metabolic dysfunction and inflammation. Moreover, we identified a heart–adipose tissue–immune cell crosstalk, which might serve as new therapeutic target in cardiac pathologies.</jats:p>